Northwestern University Lead Academic Participating Site, GY4 Supplemental Request

西北大学主导学术参与网站，GY4 补充请求

• 批准号: 10736415
• 负责人: AL B BENSON
• 金额: $ 30万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-11-11 至 2023-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10736415
• 关键词: Advanced Malignant Neoplasm; American College of Radiology Imaging Network; Ancillary Study; Area; Cancer Intervention; Chicago; Clinical Research; Clinical Trials; Collaborations; Comprehensive Cancer Center; Eastern Cooperative Oncology Group; Faculty; Goals; Home; Infrastructure; Institution; International; Lead; Leadership; Malignant Neoplasms; Patient Recruitments; Patients; Persons; Productivity; Recording of previous events; Research Infrastructure; Resources; Role; Science; Scientific Advances and Accomplishments; Site; Southwest Oncology Group; Universities; improved; inter-institutional; metropolitan; recruit; senior faculty

Summary/Abstract: The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (LCC) has a long history of NCTN participation with ECOG membership since 1973. Currently, the LCC infrastructure supports participation in clinical trials and ancillary studies through the ECOG-ACRIN, SWOG, Alliance, NRG, and COG. LCC has an established history of accruing to and participating in NCTN trials including selection as a high performing site in 2015, 2016 and 2017. In 2019, Northwestern University was designated as a Lead Academic Performing site (LAPS) and in this new role continues to significantly accrue patients to NCTN trials, exceeding planned accrual goals in both years as a LAPS institution. Through continued demonstration of significant scientific accomplishments and new initiatives, recruitment of accomplished senior faculty and productive junior faculty, comprehensive and integrated infrastructure for oversight of cancer-related clinical trials, LCC will continue to expand participation in NCTN trials, provide scientific leadership of key network activities, and increase inter-institutional collaborations and access to unique scientific resources, to advance cancer interventions.

摘要/摘要： 西北大学（LCC）的罗伯特·H·卢里（Robert H. Lurie）综合癌症中心的NCTN历史悠久 自1973年以来与ECOG成员的参与。目前，LCC基础架构支持参与 通过ECOG-ACRIN，SWOG，Alliance，NRG和COG进行的临床试验和辅助研究。 LCC有一个 既定历史的参与和参加NCTN试验的历史，包括选择作为高性能地点 2015、2016和2017。 2019年，西北大学被指定为主要学术表演地点（圈），在这个新的 角色继续显着使患者进行NCTN试验，超过了两年中计划的应计目标，因为 圈机构。 通过继续展示重大科学成就和新倡议，招募 有成就的高级教师和高产的初级教师，全面和综合基础设施 监督与癌症相关的临床试验，LCC将继续扩大参与NCTN试验，提供 关键网络活动的科学领导，并增加机构间合作并获得独特的访问 科学资源，以促进癌症干预措施。